HERTFORDSHIRE, England and PITTSBURGH, May 4, 2016 /PRNewswire/ -- In an effort to drive a national movement about the serious and unpredictable nature of anaphylaxis, a life-threatening allergic reaction, Mylan N.V. (NASDAQ, TASE: MYL), a leading global pharmaceutical company, is today unveiling an initiative called Anaphylaxis: For Reel. Through this initiative Mylan, along with actor, producer, businesswoman and mother, Sarah Jessica Parker, and leading advocacy organizations, aims to inspire greater understanding about the risks of anaphylaxis. Anaphylaxis: For Reel™ encourages young filmmakers and their families to make their voices heard by creating and submitting short, educational films about the realities of managing severe allergies. Parker, whose son has allergies to peanuts and hazelnuts, is joining this initiative to share her story and personal connection to this life-threatening health condition that affects families nationwide.

To visit the multimedia assets associated with this release, please click: http://www.multivu.com/players/English/7796131-mylan-anaphylaxis-for-reel/

Sarah Jessica Parker is publicly sharing her story as the mother of a child with potentially life-threatening (severe) allergies through Anaphylaxis: For Reel™.

"With Anaphylaxis: For Reel, I hope to help empower other families affected by severe allergies to share their personal stories," Parker said. "Like every family, we have our own story. We learned about our son's food allergies only after he experienced anaphylaxis – and I still vividly remember how scary that day was for all of us. Since then, we've come to understand just how serious the risks of anaphylaxis are – and how crucial it is to take proactive steps to manage his severe allergies."

Anaphylaxis is a significant health issue in the U.S., with up to 43 million people at risk, including children affected by food allergies, estimated at one in 13. Every six minutes, on average, food-related anaphylaxis sends someone in the U.S. to the emergency department. While avoidance of allergic triggers is the critical first step in managing severe allergies, accidental exposure can happen at any time, making it important to have an anaphylaxis action plan. This includes knowing the signs and symptoms of anaphylaxis, always having access to two epinephrine auto-injectors and knowing when to use them and seeking immediate medical care after use. Epinephrine is the only first-line treatment for anaphylaxis, and delayed administration is the single highest predictor of the rare occurrence of death. Antihistamines do not treat or relieve the life-threatening symptoms of anaphylaxis.

"Anaphylaxis is very unpredictable – symptoms can vary from person to person, and reactions can be mild one time and life-threatening the next," said Dr. Hemant Sharma, Clinical Chief of the Division of Allergy and Immunology at Children's National Health System in Washington D.C. "Our goal with this initiative is to have the real-life, everyday stories of those who deal with life-threatening allergies firsthand shine a spotlight on the urgent need to increase education about the importance of being ready to respond if anaphylaxis occurs."

A panel, including Dr. Hemant Sharma and leading advocacy organization members, will come together to select up to five films to be featured at a premiere event in New York City this fall with Parker and posted on Anaphylaxis101.com. Films can be submitted on Anaphylaxis101.com through July 11. Films will be evaluated based upon creativity, originality and adherence to submission guidelines.

The advocacy groups involved with the initiative include:                                                     

  • Allergy & Asthma Network (AAN)
  • American Latex Allergy Association (ALAA)
  • Asthma and Allergy Foundation of America (AAFA)
  • Food Allergy & Anaphylaxis Connection Team (FAACT)
  • Food Allergy Research & Education (FARE)
  • Kids with Food Allergies (KFA)

For more information about Anaphylaxis: For Reel™ and for complete rules, terms and conditions, visit Anaphylaxis101.com.

Sarah Jessica Parker and Dr. Hemant Sharma are paid spokespeople of Mylan.

About Anaphylaxis
Anaphylaxis is a life-threatening allergic reaction that has many possible triggers, occurs quickly, without warning, and must be treated immediately with epinephrine. Symptoms may include hives, itching, swelling or redness of the skin, tightness in the throat, nausea, dizziness, breathing problems, a decrease in blood pressure and/or fainting. Anaphylaxis can be caused by triggers, such as food, stinging and biting insects, medicines, latex or even exercise. While symptoms of an allergic reaction vary from person to person, reactions can quickly progress to become life-threatening.

About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our nearly 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.

Anaphylaxis: For Reel™ is a trademark owned by the Mylan companies. The Mylan logo is a registered trademark of Mylan Inc.
© 2016 Mylan Specialty L.P. All rights reserved.
NON-2016-0256

Sarah Jessica Parker is publicly sharing her story as the mother of a child with potentially life-threatening (severe) allergies through Anaphylaxis: For Reel™.

 

Dr. Hemant Sharma, allergy and immunology expert, helps raise awareness about the unpredictable nature of anaphylaxis, a life-threatening allergic reaction, through Anaphylaxis: For Reel™.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sarah-jessica-parker-shares-her-personal-experience-with-potentially-life-threatening-severe-allergies-through-mylans-anaphylaxis-for-reel-initiative-300262660.html

SOURCE Mylan N.V.

Copyright 2016 PR Newswire

Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Mylan NV Charts.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Mylan NV Charts.